Evaluation of a Night Spectacle Correction Concerning an Improvement of Mesopic Vision Quality
NCT ID: NCT02965534
Last Updated: 2019-02-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2015-10-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study was to investigate whether quality of vision in twilight or night could be improved by a spectacle correction optimized for mesopic light conditions. Moreover, objective refraction in large pupils measured by aberrometry was compared to subjective mesopic refraction.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Night Myopia and Dark Focus of Accommodation
NCT03358550
Myopia Prevention With Reading Glasses
NCT05030103
Study of Myopia Acquisition and Prevention
NCT00477620
The Effect of Eye Exercises in Individuals With Eye Refractive Defects
NCT05999552
Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents
NCT06927414
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Follow Up 1:
After two weeks, participants were asked for their subjective experiences with the first correction by a visual analogue scale questionnaire. After the evaluation, glasses were changed.
Follow Up 2:
Two weeks later, subjective experiences were evaluated again. After visual analogue scale questionnaire, subjects were asked to compare the two glasses concerning quality of mesopic vision and subjective safety level during night driving.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Night Spectacle Correction
Refraction for this glasses was obtained at low luminance.
Spectacle/Glasses
Spectacle Correction for photopic light conditions
Refraction for this glasses was obtained at high luminance level.
Spectacle/Glasses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spectacle/Glasses
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Binocular Vision
Exclusion Criteria
* Difference between habitual correction and actual refraction more than 0.5 D
* Medication with an influence on visual system
* Disease or eye disease with an effect on the visual system
* pregnancy or other hormonal variances
* influence of drugs
* mental handicap
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IGA OPTIC EG
UNKNOWN
University of Applied Sciences Jena
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephan Degle
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephan Degle, Prof.
Role: PRINCIPAL_INVESTIGATOR
University of Applied Sciences Jena
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Degle Optometry
Augsburg, Bavaria, Germany
Hessler Optometry
Klingenberg am Main, Bavaria, Germany
University of Applied Sciences
Jena, Thuringia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IGAMYO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.